fatnews.com Home page  >  Article | Previous article | Next article



  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Osteoporosis drugs are not bone builders, they are bone hardeners, and make bones brittle

    Posted by .(JavaScript must be enabled to view this email address)
    Saturday, July 27, 2019 9:14 am Email this article

    Osteoporosis drugs known as bisphosphonates (alendronate, ibandronate, risedronate and zoledronic acid) are not “bone builders”, they are “bone hardeners” which can make bones brittle according to Susan Ott, MD from the University of Washington.

    Attached is a video clip from ABC World News showing women who were taking these drugs whose femur snapped in two.


    Bisphosphonates include brand names such as Fosamax, Boniva, Reclast, Zometa, Actonel, Aclasta (alendronate, ibandronate,  risedronate and zoledronic acid).

    These drugs can cause your femur to snap in two.

    These drugs can also cause

    “Many people believe that these drugs [Fosamax and Actonel] are ‘bone builders,’ but the evidence shows that they are actually ‘bone hardeners.,’” Dr. Ott writes.

    “In fact, bone biopsy studies from patients treated with risedronate [Actonel] or alendronate [Fosamax] show that the mineralizing surface, which is forming bone, decreases 80% to 96% after 3 years of treatment.”

    “[These drugs] deposit in the skeleton with a half-life of more than 10 years.”

    “With continuous use, the drugs will accumulate [in the bones].”

    “It is possible that the bone will eventually become brittle or will be unable to repair microdamage.”

    “One-year animal studies using doses 6 times higher than recommended for humans show decreased bone formation in both spine and ileum and increased numbers of microcracks.”

    Would I [Larry Hobbs] ever take one of these drugs?


    Do I think that anyone should take one of these drugs?



    Ott S. New treatments for brittle bones. Ann Intern Med, 2004 Sep 7; 141(5): 406-407.

    Author’s Contact Info

    Susan Ott, MD
    Associate Professor of Medicine 
    Division of Metabolism, Endocrinology and Nutrition
    University of Washington Medical Center
    1959 NE Pacific
    UW Mailbox 356426
    Seattle, WA 98195-6426
    .(JavaScript must be enabled to view this email address)


    Articles on the same subject can be found here:


    Please feel free to share your comments about this article.




    Please enter the word you see in the image below:

    Remember my personal information

    Notify me of follow-up comments?

    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.